Overwhelmed by a massive outbreak, China authorizes emergency use of Merck’s COVID pill

Beijing’s decision to approve the drug, its second developed abroad after Pfizer’s Paxlovid, comes amid domestic shortages of everything from fever-reducing medicines to antivirals that prevents severe disease. Read More